Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Curodont Repair in Patients with Buccal Carious Lesions
DRKS00012941Phase 4Completed
- Sponsor
- Credentis
- Start
- Sep 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of curodont in carious lesion (2 arms), sponsored by Credentis. Started Sep 2017; status: completed.
02
Drugs
curodont
03
Conditions
carious lesion
Beyond the preview
Go deeper on DRKS00012941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012941.